Traws Pharma, Inc. ( TRAW) - Stock Earnings
TRAW Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 12, 2026, midnight | — / — | — | — / — | — |
TRAW Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -3.0 million USD | — USD |
| 2025Q4 | -7.4 million USD | — USD |
| 2026Q1 | -7.1 million USD | 57000 USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
TRAW Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -18.9 million USD | 226000 USD |
| 2024 | -54.7 million USD | 226000 USD |
| 2025 | 9.2 million USD | 2.8 million USD |
| 2026 Est. | — | — |
TRAW
Price: $0.38
52 week price:
Earnings Per Share: -1.83 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 7.9 million